Pomdoctor six-month net loss widens to RMB 238.17 million; net revenues rise 6% to RMB 185 million
POM•Pomdoctor reported a net loss of RMB 238.17 million and a 6% rise in net revenues to RMB 185 million for the six months ended June 30, 2026.
POM•Pomdoctor reported a net loss of RMB 238.17 million and a 6% rise in net revenues to RMB 185 million for the six months ended June 30, 2026.
Loss from operations widened to RMB 233.33 million. Sales and marketing expenses were RMB 76.4 million, and research and development expenses were RMB 106.27 million.
Pomdoctor reported a going-concern warning, citing a working capital deficit of RMB 137.2 million at June 30, 2026.